Navigation Links
New strategy rapidly identifies cancer targets

In a step toward personalized medicine, Howard Hughes Medical Institute investigator Brian J. Druker and colleagues have developed a new technique to identify previously unknown genetic mutations that can trigger cancerous growth. By analyzing the proteins ?instead of the genes ?inside acute myeloid leukemia (AML) cells, the researchers have dramatically reduced the time it takes to zero in on molecular abnormalities that might be vulnerable to specific drug treatments.

"This approach gives us a way to figure out what's driving the growth of a cancer in an individual patient and ultimately match that patient with the right drug," said Druker, who is based at the Oregon Health & Science University in Portland. Druker's team collaborated on the research, which was published in the July 17, 2006, issue of the journal Cancer Cell, with scientists in the lab of D. Gary Gilliland, an HHMI investigator at Brigham and Women's Hospital, as well as researchers at the Portland VA Medical Center, Cell Signaling Technology, the University of Chicago, and Yale University.

Traditionally, cancer-gene hunters have scanned the genome looking for mutations that trigger out-of-control cell growth. Druker tried this approach, but found it wanting. "We were doing some high-throughput DNA sequencing, and we weren't really finding much," he said.

Instead, the team added tools from the burgeoning field of proteomics, the study of proteins. "We decided this more functional assay would get us to the disease-causing genes more rapidly," said Druker, who has been studying a group of cell-signaling proteins called tyrosine kinases for 20 years.

Tyrosine kinases play a key role in many cancers. In healthy cells, they help form a chain of signals that prompt normal cell growth and division. Sometimes, though, a tyrosine kinase gets stuck in an "on" position, driving out-of-control cell division and, ultimately, cancer. This potentially devastating
'"/>

Source:Howard Hughes Medical Institute


Page: 1 2 3

Related biology news :

1. Gene silencing technique offers new strategy for treating, curing disease
2. AIDS expert says global strategy needed to combat feminization of HIV/AIDS
3. Asleep in the deep: Model helps assess ocean-injection strategy for combating greenhouse effect
4. Melanoma vaccine strategy shows promise in laboratory experiments
5. Study by Einstein researchers could lead to a novel strategy for treating obesity
6. Team discovers possible universal strategy to combat addiction
7. Researchers discover way to transport environmental arsenic to plant leaves in new clean-up strategy
8. Attacking cancers sweet tooth is effective strategy against tumors
9. Researchers unveil strategy for creating actively-programmed anti-cancer molecules
10. New strategy developed to combat West Nile Virus
11. Circumcision: A proven strategy to prevent HIV
Post Your Comments:
(Date:5/9/2008)... the May 2008 Pediatric Academic Societies and Asi...dicate that childhood and adolescent obesity negat... relates to cardiac health. , Obesity has been i...ears and obesity in adults has been linked to card...ildren is also increasing and many cardiovascular ...
(Date:5/9/2008)...apped their comfortable offices for one of the mos... out a challenging field campaign that is seen as ...e mission CryoSat will be as accurate as possible....any and Canada, are currently in the middle of Cry...nsive three-week experiment programme in the far n...
(Date:5/8/2008)... (UM) students have received prestigious Graduate ...ndation (NSF) for their doctoral work on coral ree... receive three years of support for their work in ...rofessor in the Division of Marine Biology and Fis...spheric Science. In addition, a third student ent...
(Date:5/8/2008)...predict aspects of fish diversity in specific rive...y drive a comprehensive suite of fish biodiversity...has been elusive. , Now a group of researchers, i...Fagan, reports success using a so-called neutral m...issippi-Missouri River System. Their study appears...
Breaking Biology News(10 mins):Study supports reason for concern in childhood and adolescent obesity 2Scientists endure Arctic for last campaign prior to CryoSat-2 launch 2Scientists endure Arctic for last campaign prior to CryoSat-2 launch 3Everything's coming up corals 2Everything's coming up corals 3Model successfully predicts large river system fish diversity 2LMS Third Quarter 2008 Financial Results Q3 Revenue Increases 88 25 to 241 0 Million YTD Revenue Increases 87 25 to 242 6 Million 11739 1LMS Third Quarter 2008 Financial Results Q3 Revenue Increases 88 25 to 241 0 Million YTD Revenue Increases 87 25 to 242 6 Million 11739 2LMS Third Quarter 2008 Financial Results Q3 Revenue Increases 88 25 to 241 0 Million YTD Revenue Increases 87 25 to 242 6 Million 11739 3LMS Third Quarter 2008 Financial Results Q3 Revenue Increases 88 25 to 241 0 Million YTD Revenue Increases 87 25 to 242 6 Million 11739 4Transplant Community Unites to Educate Capitol Hill Staffers About the Gift of Life 11734 1Transplant Community Unites to Educate Capitol Hill Staffers About the Gift of Life 11734 2Dynatronics to Release Second Quarter Results Thursday February 14 2008 3B Conference Call Set for 4 3A30 p m ET 11729 1Gen Probe to Webcast Presentation at Deutsche Bank Small and Mid Cap Growth Conference 11724 1Gen Probe to Webcast Presentation at Deutsche Bank Small and Mid Cap Growth Conference 11724 2
...rsity of California, Riverside has used chemical g...e ability of plants to alter their direction of gr... gravitropism. , The researchers screened a librar... as chemical genomics, to identify those that coul... on plant growth, which is closely linked to the m...
...n textbooks, are essential for eukaryotic cells--i...of energy as they use oxygen. However, some eukary...s--such as Entamoeba histolytica, the causal agent...re too oxygen poor to support this process. Nevert...ious organelle, called a mitosome, that is evoluti...
... student may have figured out why rates of extinct...rine life during one of the greatest ice ages of t...290 million years ago, late in the Paleozoic Era. ...rms that did survive during this era were singular...rature and sea levels. Those that were not died in...
...ntifies 34 regions worldwide where 75 percent of t...phibians survive within habitat covering just 2.3 ... to the combined areas of the five largest U.S. st...t of the Earth,s surface, an area equivalent in si...sis shows that an estimated 50 percent of all vasc...
Other Biology News:Researchers discover chemical compounds that affect plant growth 2Low level of extinction during ice age linked to adaptability 2Biodiversity hotspots identify conservation priorities 2Biodiversity hotspots identify conservation priorities 3Biodiversity hotspots identify conservation priorities 4Biodiversity hotspots identify conservation priorities 5
(Date:5/9/2008)...educed operating costs drive solid ...a, May 9 /- Warner Chilcott...lts for the quarter ended,March 31, 2008. Revenue ...,million, an increase of 5.1%, over the prior year...evenue were the net sales of our promoted,products...
(Date:5/9/2008)...ssions Include Presentations from Inst...taxis to Feature New Odyssey Information Managemen...cts in Booth 304, ST. LOUIS, May 9 /PRNewswire-Fi...nced today that its participation at Heart Rhythm ...chieved as the only provider of fully,automated, r...
(Date:5/9/2008)...ks key milestones with insulin and Apo ... TSX symbol: SBS, CALGARY, May 9 /PRNewswi... a biotechnology company developing a portfolio of...ular diseases, today announced its,2008 first quar...hts, - Prepared pilot scale quantities of insul...
(Date:5/9/2008)...FirstCall/ -- Northwest,Biotherapeutics, Inc. (AIM...announced that Al Rajhi Holdings W.L.L. ("Al Rajhi...6 2008, to provide NWBT with debt financing in,the...e terms of the Loan, Northwest will receive US$4.0...e in the principal amount of,US$4,240,000 (reflect...
Breaking Biology Technology:Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 2Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 3Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 4Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 5Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 6Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 7Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 8Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 9Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 10Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 11Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 12Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 13Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 14Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 15Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 16Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 17Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2008 2Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2008 3Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2008 4Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2008 5SemBioSys announces first quarter 2008 financial and operational results 2SemBioSys announces first quarter 2008 financial and operational results 3SemBioSys announces first quarter 2008 financial and operational results 4SemBioSys announces first quarter 2008 financial and operational results 5SemBioSys announces first quarter 2008 financial and operational results 6SemBioSys announces first quarter 2008 financial and operational results 7SemBioSys announces first quarter 2008 financial and operational results 8SemBioSys announces first quarter 2008 financial and operational results 9SemBioSys announces first quarter 2008 financial and operational results 10SemBioSys announces first quarter 2008 financial and operational results 11SemBioSys announces first quarter 2008 financial and operational results 12Northwest Secures US$4.0 Million in Debt Financing 2Northwest Secures US$4.0 Million in Debt Financing 3
..., In this BioPharm,International excl...,science and,manufacture of his,companys innov..., Dr.Zhaohui Peng is the chairman,chief...o GeneTech Co., Ltd., , Langshen Road, Sh..., 0755.2696.8818, , fax: 0755.26...
...y Chris Julien; Reprinted with permission from Ame... Scaling up from spinners, T-flasks or shaker... reap the benefits of saving time.,As an example... 5-L bioreactor has been shown to produce the equi...-flasks 1 . Moreover, a bioreactor requires only o...
..., , Introduction , ...cumenting,simple protocols for culturing cells i...ystem. The modular,BioFlo 110 is offered with a ...s to enable growth of a wide variety,of cultures...bacterial cells. Complete kits are also available....
... Michael Olive, Ph.D. , Molecular Biology... Lincoln, NE 68504 , , ABSTRACT...developing biomedical technology that enables the ... of a living animal. While several optical imaging...oluminescent reporter systems have shown utility i...
Other Biology Technology:The Genesis of Gendicine: The Story Behind the First Gene Therapy 2The Genesis of Gendicine: The Story Behind the First Gene Therapy 3The Genesis of Gendicine: The Story Behind the First Gene Therapy 4The Genesis of Gendicine: The Story Behind the First Gene Therapy 5The Genesis of Gendicine: The Story Behind the First Gene Therapy 6The Genesis of Gendicine: The Story Behind the First Gene Therapy 7The Genesis of Gendicine: The Story Behind the First Gene Therapy 8The Genesis of Gendicine: The Story Behind the First Gene Therapy 9The Genesis of Gendicine: The Story Behind the First Gene Therapy 10The Genesis of Gendicine: The Story Behind the First Gene Therapy 11The Genesis of Gendicine: The Story Behind the First Gene Therapy 12The Genesis of Gendicine: The Story Behind the First Gene Therapy 13The Genesis of Gendicine: The Story Behind the First Gene Therapy 14The Genesis of Gendicine: The Story Behind the First Gene Therapy 15Scaling-Up from Spinners, T-Flasks & Shakers: A versatile bioreactor for mammalian and microbial cells 2Scaling-Up from Spinners, T-Flasks & Shakers: A versatile bioreactor for mammalian and microbial cells 3Scaling-Up from Spinners, T-Flasks & Shakers: A versatile bioreactor for mammalian and microbial cells 4Scaling-Up from Spinners, T-Flasks & Shakers: A versatile bioreactor for mammalian and microbial cells 5Scaling-Up from Spinners, T-Flasks & Shakers: A versatile bioreactor for mammalian and microbial cells 6Insect Cell Culture Using a BioFlo 110 Benchtop Bioreactor 2Insect Cell Culture Using a BioFlo 110 Benchtop Bioreactor 3Insect Cell Culture Using a BioFlo 110 Benchtop Bioreactor 4Insect Cell Culture Using a BioFlo 110 Benchtop Bioreactor 5Insect Cell Culture Using a BioFlo 110 Benchtop Bioreactor 6Near Infrared Technology and Optical Agents For Molecular Imaging 2Near Infrared Technology and Optical Agents For Molecular Imaging 3Near Infrared Technology and Optical Agents For Molecular Imaging 4Near Infrared Technology and Optical Agents For Molecular Imaging 5Near Infrared Technology and Optical Agents For Molecular Imaging 6Near Infrared Technology and Optical Agents For Molecular Imaging 7
Request Info
Request Info
Request Info
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays.
Biology Products: